Organogenesis Holdings (ORGO) Raw Materials (2021 - 2026)

Organogenesis Holdings' Raw Materials history runs 6 years deep, the most recent figure standing at $14.5 million for Q1 2026.

• On a quarterly basis, Raw Materials rose 4.59% year-over-year to $14.5 million in Q1 2026; TTM through Mar 2026 was $14.5 million, a 4.59% increase from a year earlier, with the FY2025 full-year figure at $14.3 million, up 8.2% from the prior year.
• Raw Materials improved to $14.5 million in Q1 2026 per ORGO's latest filing, from $14.3 million in the prior quarter.
• Across five years, Raw Materials topped out at $14.5 million in Q1 2026 and bottomed at $10.2 million in Q2 2022.
• The 5-year median for Raw Materials is $13.3 million (2023), against an average of $13.2 million.
• Across the five-year window, Raw Materials jumped 36.12% in 2022 and decreased 6.42% in 2024, its largest moves.
• Year by year, Raw Materials stood at $12.3 million in 2022, then climbed by 5.75% to $13.0 million in 2023, then gained by 2.03% to $13.3 million in 2024, then advanced by 8.2% to $14.3 million in 2025, then climbed by 1.31% to $14.5 million in 2026.
• Per Business Quant, the three latest ORGO Raw Materials figures stand at $14.5 million (Q1 2026), $14.3 million (Q4 2025), and $14.1 million (Q3 2025).